MedPath

Evaluation the efficacy of adipose derived SVF cells in the treatment of acne scars

Phase 1
Conditions
atrophic scar.
Scar conditions and fibrosis of skin
L90.5
Registration Number
IRCT20200127046282N4
Lead Sponsor
Tehran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
10
Inclusion Criteria

Age between 20-50
Having middle to severe atrophic scar in face region

Exclusion Criteria

Pregnancy and breastfeeding
History of cancer
Patients with active acne
People with Mental Disorders
Active infection in the face

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Scar size. Timepoint: before and 3 month after the intervention. Method of measurement: visio face.;Side effects. Timepoint: One week after treatment. Method of measurement: Questionnaire and visit.;Patient Satisfaction. Timepoint: Three and six months after treatment. Method of measurement: Questionnaire.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath